These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
523 related items for PubMed ID: 29139039
1. Genetic screening and molecular characterization of MET alterations in non-small cell lung cancer. Saigi M, McLeer-Florin A, Pros E, Nadal E, Brambilla E, Sanchez-Cespedes M. Clin Transl Oncol; 2018 Jul; 20(7):881-888. PubMed ID: 29139039 [Abstract] [Full Text] [Related]
10. The Clinical Impact of Capmatinib in the Treatment of Advanced Non-Small Cell Lung Cancer with MET Exon 14 Skipping Mutation or Gene Amplification. Choi W, Park SY, Lee Y, Lim KY, Park M, Lee GK, Han JY. Cancer Res Treat; 2021 Oct; 53(4):1024-1032. PubMed ID: 33540494 [Abstract] [Full Text] [Related]
13. Prevalence and clinical association of MET gene overexpression and amplification in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape project. Bubendorf L, Dafni U, Schöbel M, Finn SP, Tischler V, Sejda A, Marchetti A, Thunnissen E, Verbeken EK, Warth A, Sansano I, Cheney R, Speel EJM, Nonaka D, Monkhorst K, Hager H, Martorell M, Savic S, Kerr KM, Tan Q, Tsourti Z, Geiger TR, Kammler R, Schulze K, Das-Gupta A, Shames D, Peters S, Stahel RA, Lungscape Consortium. Lung Cancer; 2017 Sep; 111():143-149. PubMed ID: 28838386 [Abstract] [Full Text] [Related]
14. Emergence of Preexisting MET Y1230C Mutation as a Resistance Mechanism to Crizotinib in NSCLC with MET Exon 14 Skipping. Ou SI, Young L, Schrock AB, Johnson A, Klempner SJ, Zhu VW, Miller VA, Ali SM. J Thorac Oncol; 2017 Jan; 12(1):137-140. PubMed ID: 27666659 [Abstract] [Full Text] [Related]
15. Prevalence of MET exon 14 skipping mutation in pulmonary sarcomatoid carcinoma patients without common targetable mutations: A single-institute study. Yu Y, Zhang Q, Zhang J, Lu S. J Cancer Res Ther; 2019 Jan; 15(4):909-913. PubMed ID: 31436251 [Abstract] [Full Text] [Related]
16. MET Exon 14 Mutations in Non-Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression. Awad MM, Oxnard GR, Jackman DM, Savukoski DO, Hall D, Shivdasani P, Heng JC, Dahlberg SE, Jänne PA, Verma S, Christensen J, Hammerman PS, Sholl LM. J Clin Oncol; 2016 Mar 01; 34(7):721-30. PubMed ID: 26729443 [Abstract] [Full Text] [Related]
18. c-MET/phospho-MET protein expression and MET gene copy number in non-small cell lung carcinomas. Tsuta K, Kozu Y, Mimae T, Yoshida A, Kohno T, Sekine I, Tamura T, Asamura H, Furuta K, Tsuda H. J Thorac Oncol; 2012 Feb 01; 7(2):331-9. PubMed ID: 22198430 [Abstract] [Full Text] [Related]